Catalyst Wire Dossier Catalyst Wire Dossier

Abobotulinum Toxin

abobotulinum toxin type A · Ipsen
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Abobotulinum Toxin, covering 2021-03-09 to 2026-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients [Phase 3]

See pricing